Paper8945698
Why would anyone have expected anything else? Characteristics of materials distributed by drug companies: four points of view.
Temple R and 1 other. J Gen Intern Med, 1996. Cited by 6 papers, by iCite.
Cite this record
ConductScience Library. Why would anyone have expected anything else? Characteristics of materials distributed by drug companies: four points of view. Papers, record 8945698. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8945698
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Why would anyone have expected anything else? Characteristics of materials distributed by drug companies: four points of view.
- PubMed
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Drug Industry | Major topic |
| Drug Utilization | Major topic |
| Humans | |
| United States | |
| United States Food and Drug Administration |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment on | 8945688 | Characteristics of materials distributed by drug companies. An evaluation of appropriateness. | https://conductscience.org/library/papers/8945688 |
Source PubMed
References1
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|---|
| 1 | 8945688 | Characteristics of materials distributed by drug companies. An evaluation of appropriateness. | J Gen Intern Med | 1996 | https://conductscience.org/library/papers/8945688 |
Source PubMed
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 11885831 | Selling drugs to the public--should the UK follow the example of the US? | Br J Gen Pract | 2002 | https://conductscience.org/library/papers/11885831 | PubMed |
| 11885830 | Selling drugs to doctors--it's marketing, not education. | Br J Gen Pract | 2002 | https://conductscience.org/library/papers/11885830 | PubMed |
| 10578674 | Pharmaceutical advertising revenue and physician organizations: how much is too much? | West J Med | 1999 | https://conductscience.org/library/papers/10578674 | PubMed |
| 8945699 | Drug companies and information about drugs: recommendations for doctors. Characteristics of materials distributed by drug companies: four points of view. | J Gen Intern Med | 1996 | https://conductscience.org/library/papers/8945699 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8945698
GET https://conductscience.org/api/papers/v1/8945698/authors